Beginning in March 2012, all orders from European customers are being processed through DeRoyal Global Healthcare Solutions, Ltd. This now gives DeRoyal the ability to accept orders and invoice them in Euro or US dollars, depending on the customers’ preferences.
Bill Pittman, DeRoyal’s President and Chief Operating Officer, stated, “Besides the market share gains we have enjoyed in the United States over the last several years, our growth in other markets such as Canada, Mexico, Central & South America, the Middle East, Northern Africa, and the South Pacific has shown that DeRoyal is respected internationally and that our products and services continue to improve care to patients worldwide. The opening of this office is just one way that can also improve business to better service the needs of our European partners.”
This is one of several changes that DeRoyal is implementing as it grows its international business. Additional forthcoming changes will further bolster DeRoyal’s ability to conduct business, improve operations and logistics, and service customers in their respective markets.
# # #
Founded in 1973, medical device manufacturer DeRoyal is committed to improving both the clinical quality and economic health of its customers. With 2,000 employees, 2.5 million square feet under roof, operations in six countries and six U.S. states and manufacturing assets on three continents, DeRoyal brings value to its customers in several distinct markets; these include surgical devices, unitized delivery systems, orthopedic supports & bracing, wound care dressings as well as orthopedic implants. Key core competencies include injection molding, device assembly, metal fabrication, converting, electronics assembly as well as sterilization services. DeRoyal combines these fundamental manufacturing capabilities with its own unique services and information technology tools to deliver unparalleled value to its customers with a particular expertise in disrupting dysfunctional markets.